Charles Schwab Investment Management Inc. Sells 16,850 Shares of Nature's Sunshine Products, Inc. $NATR

Charles Schwab Investment Management Inc. decreased its holdings in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) by 24.5% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,028 shares of the company's stock after selling 16,850 shares during the period. Charles Schwab Investment Management Inc. owned 0.28% of Nature's Sunshine Products worth $653,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Mackenzie Financial Corp bought a new position in shares of Nature's Sunshine Products during the first quarter valued at approximately $287,000. Skylands Capital LLC grew its holdings in shares of Nature's Sunshine Products by 1.7% during the first quarter. Skylands Capital LLC now owns 431,800 shares of the company's stock valued at $5,419,000 after buying an additional 7,209 shares during the last quarter. Janney Montgomery Scott LLC purchased a new stake in shares of Nature's Sunshine Products during the first quarter valued at approximately $340,000. GAMMA Investing LLC grew its holdings in shares of Nature's Sunshine Products by 2,090.2% during the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after buying an additional 2,132 shares during the last quarter. Finally, Millennium Management LLC purchased a new stake in shares of Nature's Sunshine Products during the fourth quarter valued at approximately $1,135,000. Institutional investors own 79.40% of the company's stock.

Nature's Sunshine Products Stock Down 1.2%

NATR traded down $0.20 during trading on Friday, hitting $17.14. The company's stock had a trading volume of 82,208 shares, compared to its average volume of 115,389. Nature's Sunshine Products, Inc. has a one year low of $11.01 and a one year high of $18.06. The firm has a market cap of $302.28 million, a PE ratio of 23.16 and a beta of 1.11. The business's 50 day simple moving average is $15.78 and its 200-day simple moving average is $14.28.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.19. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The business had revenue of $114.75 million for the quarter, compared to the consensus estimate of $113.10 million. Nature's Sunshine Products has set its FY 2025 guidance at EPS.

Analysts Set New Price Targets

A number of research firms have recently commented on NATR. DA Davidson reiterated a "buy" rating and set a $19.00 price target on shares of Nature's Sunshine Products in a report on Tuesday, June 3rd. Canaccord Genuity Group raised their target price on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $19.67.

Insider Buying and Selling at Nature's Sunshine Products

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the firm's stock in a transaction on Friday, June 27th. The shares were sold at an average price of $11.46, for a total transaction of $32,713,796.22. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Nathan G. Brower sold 9,996 shares of Nature's Sunshine Products stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $16.54, for a total transaction of $165,333.84. Following the completion of the sale, the executive vice president owned 48,277 shares in the company, valued at approximately $798,501.58. This represents a 17.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,879,275 shares of company stock valued at $33,123,599 over the last three months. Insiders own 4.70% of the company's stock.

About Nature's Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.